Search Results
Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel
Paclitaxel and sirolimus coated balloons: create evidence before claims - EuroPCR 2021
OVERCOMING THE LIMITATIONS OF PACLITAXEL - SIROLIMUS COATED BALLOON FOR THE TREATMENT OF PVD
IS SIROLIMUS EMERGING AS A POTENTIAL FUTURE TREATMENT STRATEGY INPAD OVER PACLITAXEL?
Sirolimus-Coated Balloons | Clinical Updates and Potential Advantages | TCT Connect 2020 Symposium
DCB Coronary - Paclitaxel vs Sirolimus, Dr. Bruno Scheller
Sirolimus coated balloon can TRANSFORM PCI in small vessels
CRT 2022 - What Are the Challenges for Sirolimus Coated Balloons - Dr. Aloke Finn
The future of drug-coated balloon technology - EuroPCR 2019
ABILITY to TRANSFORM treatment: innovative nanotechnology-based sirolimus DES and DCB... EuroPCR2022
Sirolimus has “a much wider” safety window and shows fewer local effects than paclitaxel
Sirolimus Coated Balloon - What Future Holds for Peripheral Artery Disease - CX Symposium 2021
